## Lisinopril-Model
Whole-body PBPK model of Lisinopril.

### Repository files
Within this repository, we share a whole-body PBPK model of Lisinopril that has been carefully developed using 4 clinical studies of intravenous or oral administration, covering a broad dosing range (2.64 - 20 mg). 

The PK-Sim project file contains simulation examples and the observed data of all clinical studies used for model development and evaluation. 

### Version information
PK-Sim Version 11.

## Code of conduct
Everyone interacting in the Open Systems Pharmacology community (codebases, issue trackers, chat rooms, mailing lists etc...) is expected to follow the Open Systems Pharmacology [code of conduct](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CODE_OF_CONDUCT.md#contributor-covenant-code-of-conduct).

## Contribution
We encourage contribution to the Open Systems Pharmacology community. Before getting started please read the [contribution guidelines](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CONTRIBUTING.md#ways-to-contribute). If you are contributing code, please be familiar with the [coding standard](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CODING_STANDARDS.md#visual-studio-settings).

## License
The model code is distributed under the [GPLv2 License](https://github.com/Open-Systems-Pharmacology/Suite/blob/develop/LICENSE).
